Medicines Transparency in Uganda

770 views
708 views

Published on

Presentation on the medicines supply situation in Uganda, at the launch of the Medicines Transparency Alliance (MeTA) in London, May 2008

1 Comment
0 Likes
Statistics
Notes
  • http://www.fioricetsupply.com is the place to resolve the price problem. Buy now and make a deal for you.
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • Be the first to like this

No Downloads
Views
Total views
770
On SlideShare
0
From Embeds
0
Number of Embeds
11
Actions
Shares
0
Downloads
6
Comments
1
Likes
0
Embeds 0
No embeds

No notes for slide
  • Title of presentation 04/06/09 MeTA
  • Medicines Transparency in Uganda

    1. 1. Country presentation UGANDA DR S ZARAMBA DIRECTOR GENERAL HEALTH SERVICES LANCASTER HOUSE, LONDON 16TH MAY 2008 04/06/09
    2. 2. MeTA ARRANGEMENTS IN UGANDA <ul><li>National coordination to be done by existing Medicines & Supplies Technical working Group </li></ul><ul><li>Activity management to be done by a sub group of the TWG – key partners e.g. Government, CSO, Academia, WHO and private sector </li></ul><ul><li>Secretariat to be the Pharmacy Division in the Ministry of Health </li></ul><ul><li>Funds held in Partnership account-(jointly managed by government & partners) </li></ul>04/06/09
    3. 3. TRANSPARENCY & ACCOUNTABILITY <ul><li>Commitment to transparency of information through a dedicated website, print and electronic media, and by other means. </li></ul><ul><li>Content to be determined by work plan and activities </li></ul>04/06/09
    4. 4. STATUS OF MeTA WORK PLAN <ul><li>Work plan to be developed in consultation with agreed structures & stakeholders </li></ul><ul><li>MeTA Secretariat visit requested as soon as possible </li></ul><ul><li>Proposal to be submitted to the International Secretariat by end of July 2008 </li></ul><ul><li>National launch possibly July 2008 </li></ul>04/06/09
    5. 5. KEY ISSUES FOR MeTA IN UGANDA <ul><li>Sub-optimal availability of essential medicines </li></ul><ul><li>High prices in retail outlets and dispensing Doctors </li></ul><ul><li>Mistrust of quality of generics by the public </li></ul><ul><li>Low level of consumer empowerment </li></ul>04/06/09
    6. 6. SOME PLANNED ACTIVITIES <ul><li>Monitoring of prices & availability continues </li></ul><ul><li>Monitoring quality - reassurance for the public on generics </li></ul><ul><li>Interventions to improve availability in health facilities </li></ul><ul><li>Interventions to improve rational use of medicines - prescribers & consumers </li></ul>04/06/09
    7. 7. NATIONAL RESEARCH NEEDS <ul><li>Baseline studies to identify gaps for research & interventions </li></ul>04/06/09
    8. 8. SUPPORT NEEDS <ul><li>Capacity building for civil society </li></ul><ul><li>Technical support to the country group – such as website design, quality of information to be shared, advocacy / use of media </li></ul><ul><li>Regional & International linkages / learning </li></ul>04/06/09
    9. 9. LESSONS LEARNED <ul><li>Experience of DFID funded multi-stakeholder Collaboration Project on medicines (GOV-CSO-WHO), provides a firm foundation for MeTA. </li></ul>06/04/09

    ×